APERTURED NONWOVEN
    1.
    发明申请
    APERTURED NONWOVEN 审中-公开

    公开(公告)号:WO2021208008A1

    公开(公告)日:2021-10-21

    申请号:PCT/CN2020/085097

    申请日:2020-04-16

    Abstract: The present invention relates to apertured nonwovens (30) comprising a first nonwoven layer comprising cellulose-based fibers and a plurality of apertures (302), wherein the plurality apertures (302) have a minimum aperture distance between two adjacent apertures which has a relative standard deviation no greater than about 40%, as measured according to the Aperture Quality Test, and either the apertures (302) has an aperture size no greater than about 2.2mm 2 and have an occlusion no greater than about 9%, as measured according to the Aperture Quality Test, or wherein the apertures (302) have an aspect ratio no greater than about 2.5 as measured according to the Aspect Ratio Test. The present invention also relates to an apertured nonwoven (30) comprising a first nonwoven layer comprising cellulose-based fibers and a plurality of apertures (302), the apertures (302) formed by pin-hole aperturing, wherein the plurality apertures (302) have a minimum aperture distance between two adjacent apertures which have a relative standard deviation no greater than about 40%, as measured according to the Aperture Quality Test.

    REDUCED-REFERENCE VISUAL COMMUNICATION QUALITY ASSESSMENT USING DATA HIDING

    公开(公告)号:WO2006107858A3

    公开(公告)日:2006-10-12

    申请号:PCT/US2006/012282

    申请日:2006-04-04

    Abstract: A method and system of communicating visual communication quality information, includes extracting reduced-reference (RR) feature data from visual content, embedding the RR feature data in the visual content; and transmitting the visual content with the embedded RR feature data. Visual communication quality is assessed by receiving visual content which includes visual content data and a first set of embedded RR feature data, retrieving the first set of RR feature data from the visual content data, and generating a second set of RR feature data from the visual content data. The second set of RR feature data corresponds to substantially identical features of the visual content data as that used to generate the first set of RR feature data. The first set of RR feature data is compared to the second first set of RR feature data to determine a quality of the visual content based upon the comparison.

    OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
    6.
    发明申请
    OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION 审中-公开
    用于治疗眼部高血压的眼科组合物

    公开(公告)号:WO2005026128A1

    公开(公告)日:2005-03-24

    申请号:PCT/US2004/028266

    申请日:2004-08-31

    CPC classification number: C07D401/06 C07F9/65038 C07F9/65583

    Abstract: This invention relates to potent potassium channel blocker compounds of Formula (I) or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans, or a pharmaceutically acceptable salt, in vivo hydrolysable ester, enantiomer, diastereomer or mixture thereof: formula (II) represents C 6-10 aryl or C 3-10 heterocyclyl, said aryl or heterocyclyl optionally substituted with 1-3 groups selected from R a ; Z represents (CH 2 ) n PO(OR)(OR*).

    Abstract translation: 本发明涉及式(I)的有效钾通道阻断剂化合物或其制剂用于治疗青光眼和导致患者眼睛中眼内压升高的其它病症。 本发明还涉及这样的化合物在哺乳动物物种,特别是人类或其药学上可接受的盐体内可水解的酯,对映异构体,非对映异构体或其混合物中对眼睛的神经保护作用的用途:式(II)代表C6- 10芳基或C 3-10杂环基,所述芳基或杂环基任选被1-3个选自R a; Z表示(CH 2)n PO(OR)(OR *)。

    PIPERIDINES, PYRROLIDINES AND HEXAHYDRO-1H-AZEPINES PROMOTE RELEASE OF GROWTH HORMONE
    10.
    发明申请
    PIPERIDINES, PYRROLIDINES AND HEXAHYDRO-1H-AZEPINES PROMOTE RELEASE OF GROWTH HORMONE 审中-公开
    哌嗪,吡咯烷酮和十六氢-1H-AZEPINES促进生长激素释放

    公开(公告)号:WO1997036873A1

    公开(公告)日:1997-10-09

    申请号:PCT/US1997005378

    申请日:1997-03-31

    CPC classification number: C07K5/021 A61K38/00 C07K5/0202 C07K5/0802

    Abstract: The present invention is directed to certain piperidines, pyrrolidines, and hexahydro-1H-azepines of general structural formula (I), wherein B is selected from (a) and (b), and R , R , R , R , R , R , R , R , R , R , D, X, Y, n, x and y are as defined herein. These compounds promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to treat physiological or medical conditions characterized by a deficiency in growth hormone secretion, such as short stature in growth hormone deficient children, and to treat medical conditions which are improved by the anabolic effects of growth hormone. Growth hormone releasing compositions containing such compounds as the active ingredient thereof are also disclosed.

    Abstract translation: 本发明涉及一般结构式(I)的某些哌啶,吡咯烷和六氢-1H-吖庚因,其中B选自(a)和(b),R 1,R 1a,R R 2a,R 4a,R 4b,R 4c,R 5,D,X,Y,n,x和y 如本文所定义。 这些化合物促进人和动物中生长激素的释放。 这种性质可以用于促进食用动物的生长,使食用肉制品的生产更有效,并且在人类中,用于治疗特征为生长激素分泌不足的生理或医学状况,例如生长激素缺乏的身材矮小 儿童,并且治疗通过生长激素的合成代谢作用改善的医疗状况。 还公开了含有这些化合物作为其活性成分的生长激素释放组合物。

Patent Agency Ranking